Ovarian cancer: what’s new, where next?

The recent RDOG studies have confirmed the value of CT in the management of ovarian cancer. However we now know that metastases to the ovary may exactly mimic primary cancer. This demands a firm histological diagnosis when surgery is not planned and especially with a history of breast and gastrointe...

Descripción completa

Detalles Bibliográficos
Autor principal: A Spencer, John
Formato: Texto
Lenguaje:English
Publicado: e-MED 2003
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434523/
https://www.ncbi.nlm.nih.gov/pubmed/18211856
http://dx.doi.org/10.1102/1470-7330.2003.0030
Descripción
Sumario:The recent RDOG studies have confirmed the value of CT in the management of ovarian cancer. However we now know that metastases to the ovary may exactly mimic primary cancer. This demands a firm histological diagnosis when surgery is not planned and especially with a history of breast and gastrointestinal tract cancer. CT guided needle biopsy can provide this.

Ejemplares similares